
Opinion|Videos|August 28, 2024
Impact of GnRH Agonists and Antagonists on Cardiovascular Outcomes in Prostate Cancer
Stephen Freedland, MD, discusses the role of GnRH agonists and antagonists on improving cardiovascular outcomes in patients with prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What insights do data show regarding GnRH agonists and GnRH antagonists and cardiovascular outcomes? If a patient has prior CVD, should they be treated with a GnRH antagonist?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
4
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
5













